(22273897), B. I., (22273900), M. S., (20806494), S. K., (22273903), S. T., (22273906), A. O., (22273909), T. I., . . . (18287202), H. N. (2025). Figure 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer.
Chicago-viite (17. p.)(22273897), Bunpei Isoda, et al. Figure 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer. 2025.
MLA-viite (9. p.)(22273897), Bunpei Isoda, et al. Figure 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer. 2025.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.